FMS Fresenius Medical Care AG: רווח למניה לשנה מתגלגלת

Fresenius Medical Care relies on inelastic demand for dialysis, which ensures a predictable cash flow. Comparable annual EPS TTM growth visualizes this resilience, where the current parameter equals 26.00. Business efficiency is supported by the complex logistics of heavy solutions and the balance between US government tariffs and medical staffing costs.
FMS (Fresenius Medical Care AG & Co. KGaA): פילוחים אנליטיים ודוחות לפי אינדיקטורים

This indicator serves as a critical filter during asset stress testing to identify real profitability trends. The metric measures the percentage change in net earnings per share over a rolling year, reflecting the efficiency of business capitalization. Analyzing the annual EPS growth rate over the last 12 months allows for an assessment of the revenue stability of Fresenius Medical Care (FMS). The stability of this figure confirms the success of the strategy to optimize cross-border deliveries and establish independent logistics hubs.